Filing Details
Celularity Inc (NASDAQ:CELU) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 20, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CELU
Celularity Inc (CELU) Files Quarterly Report for Q0
Celularity Inc (NASDAQ:CELU) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 20, 2026.
At publication ·
What changed
Celularity Inc (NASDAQ:CELU) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Celularity Inc filed its quarterly report (Form 10-Q) with the SEC on October 20, 2026.
- The company's stock trades at $1.26 with a market capitalization of $39.9 million.
- The 10-Q contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
Celularity Inc's stock currently trades at $1.26 with a market capitalization of $39.9M.
The 10-Q provides Celularity Inc's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Celularity Inc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CELU Stock Page
Frequently Asked Questions
Where can I read CELU's SEC filings?
Browse all filings on our CELU SEC filings page.
What types of SEC filings does Celularity Inc file?
Public companies like Celularity Inc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.